AlivaMab Discovery Services was established by Ablexis in response to many prospective partners wanting to outsource discovery to a scientifically-driven organization led by a team with in-the-trenches experience and real understanding of therapeutic antibody discovery and development. AlivaMab Discovery Services leverages the AlivaMab Mouse, developed by Ablexis as the platform for discovery projects conducted on behalf of clients. For more information, visit www.alivamab.com.